Drugs with high therapeutic value
The drugs in this sector especially affect the cardiovascular area with particular attention to hypertension, osteoporosis and critical ischemia.
The Immuno-Oncologic Therapeutic area of Italfarmaco is acknowledged by the Italian oncologic community as a reference point in the specialist sector thanks to the originality of its products, the innovative pharmaceutical solutions and the innovation of experimental protocols.
The activities in the field of prophylaxis, thrombosis and critical ischemia is strengthened by a long experience that comes with Calciparine, unfractionated heparin, and finds its evolution in Nadroparin Calcium, a low molecular weight heparin.
The commitment of Italfarmaco in the gynecological therapeutic area is aimed at the development of innovative and complete solutions studied for the different steps of a woman’s life, in relation to Anemia, Fertility, Pregnancy, Menopause, Gynecological Infection and inflammation area.
The goal of this area is to provide physicians with solutions for still unmet therapeutic requirements for diseases of the Central Nervous System, thanks to the innovative ability in pharmaceutical technologies of our laboratories.
The “Journal of Medicinal Chemistry” publishes a paper on the identification of new and highly selective inhibitors of histone deacetylase 6 (HDAC6) by the Italfarmaco drug discovery team.